Page 4 of 15
Preconception Care
Besides educating patients about their condition and the risks associated, note the following:
Studies indicate1 that antihypertensive treatment for the duration of at least five years offers the greatest clinical benefit to women age 30-54 in preventing a cardiovascular event.
Women with HTN should be evaluated to rule out a potentially reversible condition (i.e. pheochromocytoma)
In addition, before conceiving women should be evaluated for end-organ damage in order to establish a baseline; the following can impact pregnancy outcomes or progress during pregnancy:
ventricular hypertrophy
retinopathy
renal disease
No studies have been done at this time to demonstrate the efficacy of specific preconception interventions related to chronic HTN.